Georgia Institute for Clinical Research,LLC

Marietta, Georgia 30060

0 studies enrolling now · 22 studies all time

What they study most

Analgesia, Back Pain Lower Back Chronic, Chronic Low Back Pain, Chronic Noncancer Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain, Degenerative Disc Disease, Knee Osteoarthritis, Low Back Pain, Lumbar Disc Herniation, Migraine, Neuropathic Pain

Studies at this site

• SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study) — Completed
• Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain — Completed
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine — Completed
• Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain — Completed
• Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain — Completed
• Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain — Completed
• A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain — Completed
• An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA — Completed
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time — Completed
• Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time — Completed
• A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• A Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis (OA) — Completed